Chest-oscillation airway secretion-clearing system

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

제공처:

MGC Diagnostics Australia Pty Ltd

수업:

Class IIa

Manufactured by:

Respinnovation SAS 611 Chemin de l'Ardrech, Seillans, 83440 France

치료 영역:

38124 - Chest-oscillation airway secretion-clearing system

치료 징후:

The RespIn 11 is intended to provide bronchial clearance therapy when external manipulation of the thorax is the physician's choice of treatment. Indications for this form of therapy are described by the American Association for Respiratory Care (AARC) in the Clinical Practices Guidelines for Postural Drainage Therapy' (1991). According to AARC guidelines, specific indications for external manipulation of the thorax include evidence or a suggestion of retained secretions, evidence that the patient is having difficulty with secretion clearance, or presence of atelectasis caused by mucus plugging. In addition, the RespIn 11 is also indicated for external manipulation of the thorax to promote bronchial clearance or improve bronchial drainage for purposes of collecting mucus for diagnostic evaluation

승인 상태:

A

승인 날짜:

2019-08-22